1 Min Read
* Caladrius Biosciences reports 2017 second quarter results
* Q2 loss per share $0.22 from continuing operations Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.